Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alnylam Pharmaceuticals, Inc.    ALNY

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/26/2015 08/27/2015 08/28/2015 08/31/2015 09/01/2015 Date
102.25(c) 104.9(c) 109.07(c) 102.91(c) 97.9(c) Last
903 610 740 447 723 192 1 675 888 896 571 Volume
+6.82% +2.59% +3.98% -5.65% -4.87% Change
More quotes
Financials ($)
Sales 2015 45,9 M
EBIT 2015 -277 M
Net income 2015 -273 M
Finance 2015 409 M
Yield 2015 -
Sales 2016 55,7 M
EBIT 2016 -309 M
Net income 2016 -313 M
Finance 2016 329 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 172x
EV / Sales 2016 143x
Capitalization 8 284 M
More Financials
Company
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which discovery, development and commercialization of RNAi therapeutics.It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases.The... 
More about the company
Surperformance© ratings of Alnylam Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALNYLAM PHARMACEUTICALS, I
08/31 MEDICINES : shares surge on upbeat cholesterol drug study
08/17 ALNYLAM PHARMACEUTICALS : University of Texas System, Alnylam Pharmaceuticals As..
08/12 ALNYLAM PHARMACEUTICALS : Reports Second Quarter 2015 Financial Results and High..
08/06 ALNYLAM PHARMACEUTICALS : reports 2Q loss
08/06 ALNYLAM PHARMACEUTICALS : Results of Operations and Financial Condition, Financi..
08/06 ALNYLAM PHARMACEUTICALS : Reports Second Quarter 2015 Financial Results and High..
08/05 ALNYLAM PHARMACEUTICALS : to Webcast Presentation at Canaccord Genuity 35th Annu..
07/31 ALNYLAM PHARMACEUTICALS : Introduces Phase 1/2 Clinical Trial for ALN-AAT
More news
Sector news : Biotechnology & Medical Research - NEC
09/01 INCYTE : to Present at Upcoming Investor Conferences
08/31 GENMAB A/S : Total Number of Voting Rights and Total Share Capital
08/28 QUINTILES TRANSNATIONAL : CEO to Present at UBS Best of Americas 2015 Conference
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
09/01 PREMARKET BIOTECH DIGEST : Natural Killer Cells, Lipocine NDA, FDA Calendar
08/31 BIOTECH REVIEW (PART 2 OF 3) : New Coverage Of Some Mid-Caps With Update On Inte..
08/31 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
08/31 Alnylam and The Medicines Co's long-acting cholesterol fighter comparable to ..
08/27 PREMARKET BIOTECH DIGEST : CLL Treatment, Gilead CEO Sells, Acelity IPO


Comments 
Advertisement
Chart ALNYLAM PHARMACEUTICALS, I
Duration : Period :
Alnylam Pharmaceuticals, I Technical Analysis Chart | ALNY | US02043Q1076 | 4-Traders
Full-screen chart
Technical analysis trends ALNYLAM PHARMACEU...
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions